Research
Throughout the past 30 years, pneumologist Pablo Cortés has researched the mechanisms of coughing, and the potential treatments that can effectively treat it at the root cause.
During his research, he discovered that most cough medications on the market only suppress symptoms instead of treating the originating factors that produce cough. For this reason, he has been developing a formulation that effectively treats the root cause of the cough in humans: the “postnasal drip”
International Patent
New cough suppressant (antitussive) medication formula
Dr. Cortés has patented an antitussive (cough suppressant) medication for children and adults. The patented formula uses two active ingredients which have been scientifically proven to be safe for children and adults: oxymetazoline and ipratropium.
The medication is administered topically/nasally, effectively reducing nasal secretions that mechanically stimulate the hypopharyngeal and laryngeal receptors responsible for producing cough.